Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

3.8K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.8K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

5.4K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.4K
Types of Hormones02:13

Types of Hormones

83.3K
Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
83.3K
Hormonal Regulation01:33

Hormonal Regulation

36.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.0K
Hormonal Regulation01:40

Hormonal Regulation

48.0K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
48.0K
Plant Hormones01:56

Plant Hormones

27.5K
Plant hormones—or phytohormones—are chemical molecules that modulate one or more physiological processes of a plant. In animals, hormones are often produced in specific glands and circulated via the circulatory system. However, plants lack hormone-producing glands.
27.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Iron excess is associated with atheroma presence and progression in chronic kidney disease in the NEFRONA cohort.

Scientific reports·2026
Same author

Circulating microRNAs as potential predictive biomarkers of equine metabolic syndrome.

Veterinary journal (London, England : 1997)·2026
Same author

Corrigendum to "Antidiabetic sitagliptin influences tissue regeneration by affecting progenitor cells" [Biomed. Pharmacother. 189 (2025) 118279].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Defining interstitial lung disease related to idiopathic inflammatory myopathies: a systematic review protocol of the Myositis Clinical Trial Consortium (MCTC).

Systematic reviews·2026
Same author

Circulating α-Klotho and Multidimensional Aging and Frailty Outcomes: A Systematic Review and Meta-Analysis from the European Renal Association CKD-MBD Working Group.

Calcified tissue international·2026
Same author

Supplementation with <i>Enterococcus lactis</i> (SF68) and its association with biochemical parameters and inflammatory biomarkers related to renal impairment in dogs with chronic kidney disease.

The veterinary quarterly·2026

Related Experiment Video

Updated: Jan 27, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

4.8K

Calcimimetics maintain bone turnover in uremic rats despite the concomitant decrease in parathyroid hormone

Juan M Díaz-Tocados1, María E Rodríguez-Ortiz2, Yolanda Almadén3

  • 1Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain; Nephrology Service, Reina Sofia University Hospital, Cordoba, Spain; University of Cordoba, Cordoba, Spain; Spanish Renal Research Network (REDinREN), Institute of Health Carlos III, Madrid, Spain.

Kidney International
|March 18, 2019
PubMed
Summary

Calcimimetics directly stimulate bone formation by activating the calcium-sensing receptor (CaSR) on bone cells. This anabolic effect in bone counteracts reduced parathyroid hormone (PTH) levels, offering new therapeutic insights.

Keywords:
CaSRbonecalcimimeticchronic kidney diseasemineral metabolismparathyroid hormone

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

2.3K
Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
03:48

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research

Published on: March 1, 2024

1.6K

Related Experiment Videos

Last Updated: Jan 27, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

4.8K
Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

2.3K
Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
03:48

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research

Published on: March 1, 2024

1.6K

Area of Science:

  • Bone biology
  • Endocrinology
  • Pharmacology

Background:

  • Calcimimetics reduce parathyroid hormone (PTH) in secondary hyperparathyroidism.
  • The direct impact of calcimimetics on bone cells expressing the calcium-sensing receptor (CaSR) remains unclear.

Purpose of the Study:

  • To investigate the direct effects of calcimimetics on bone cells via CaSR activation.
  • To evaluate the in vitro and in vivo bone effects of a specific calcimimetic (AMG 641).

Main Methods:

  • Utilized a rat model with and without uremia, employing total parathyroidectomy and continuous PTH infusion to establish a PTH clamp.
  • Administered a calcimimetic (AMG 641) or vehicle to assess bone parameters.
  • Conducted in vitro studies using an osteosarcoma cell line and human bone marrow mesenchymal stem cells.

Main Results:

  • Calcimimetic treatment increased osteoblast number and osteoid volume in normal rats under PTH clamp.
  • In uremic rats, calcimimetics decreased plasma PTH and enhanced osteoblast number, osteoid surface, and bone formation at higher PTH levels.
  • In vitro, the calcimimetic promoted osteogenic gene expression, Erk1/2 phosphorylation, and osteogenic differentiation of stem cells.

Conclusions:

  • Calcimimetic administration exerts a direct anabolic effect on bone.
  • This anabolic bone effect counterbalances the reduction in PTH levels caused by calcimimetics.
  • Findings suggest a direct therapeutic potential of calcimimetics on bone health beyond PTH suppression.